Cargando…

Regional Therapy for Recurrent Metastatic Melanoma Confined to the Extremity: Hyperthermic Isolated Limb Perfusion vs. Isolated Limb Infusion

Melanoma patients with recurrent disease confined to an extremity can be offered one of two regional therapies that both give high complete response rates. Isolated limb infusion (ILI) is a newer technique performed with catheters and tourniquets that has a reduced potential morbidity, decreased eff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Reintgen, Michael, Reintgen, Christian, Nobo, Christopher, Giuliano, Rosemary, Shivers, Steven, Reintgen, Douglas
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Molecular Diversity Preservation International 2010
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3827590/ https://www.ncbi.nlm.nih.gov/pubmed/24281032 http://dx.doi.org/10.3390/cancers20100043

Ejemplares similares

Cisplatin and platinum pharmacokinetics during hyperthermic isolated limb perfusion for human tumours of the extremities.
por: Guchelaar, H. J., et al.
Publicado: (1992)

Surgical Treatment of Displaced Olecranon Fracture Through a Persistent Physis: Case Report and Review of the Literature
por: Reintgen, Christian, et al.
Publicado: (2019)

Efficacy of hyperthermic isolated limb perfusion in the treatment of locally recurrent high-grade soft tissue sarcoma of the extremities
por: Farzaliyev, Farhad, et al.
Publicado: (2020)

Anesthesia management of patients undergoing hyperthermic isolated limb perfusion with melphalan for melanoma treatment: an analysis of 17 cases
por: Ruschulte, Heiner, et al.
Publicado: (2013)

Use Patterns and Costs of Isolated Limb Perfusion and Infusion in the Treatment of Regional Metastatic Melanoma: A Retrospective Database Analysis
por: Ma, Qiufei, et al.
Publicado: (2016)

Hyperthermic Isolated Limb Perfusion with TNF α and Cisplatin in the Treatment of Osteosarcoma of the Extremities: A Feasibility Study in Healthy Dogs
por: Van Ginkel, Robert J., et al.
Publicado: (1999)

Expression of Chemoresistance-Related Genes and Heat Shock Protein 72 in Hyperthermic Isolated Limb Perfusion of Malignant Melanoma: An Experimental Study
por: Knorr, C., et al.
Publicado: (2010)

Toxicity and morbility after isolated lower limb perfusion in 242 chemo-hyperthermal treatments for cutaneous melanoma: The experience of the Tuscan Reference Centre
por: Pace, Marcello, et al.
Publicado: (2008)

The pharmacokinetic advantages of isolated limb perfusion with melphalan for malignant melanoma.
por: Scott, R. N., et al.
Publicado: (1992)

Current management of melanoma patients with nodal metastases
por: Han, Dale, et al.
Publicado: (2021)

Treatment of Locally Advanced Melanoma by Isolated Limb Infusion with Cytotoxic Drugs
por: Kroon, Hidde M.
Publicado: (2011)

Isolated Limb Perfusion with Melphalan and TNF-α in the Treatment of Extremity Sarcoma
por: Verhoef, Cornelis, et al.
Publicado: (2007)

Drug dosage in isolated limb perfusion: evaluation of a limb volume model for extremity volume calculation
por: Podleska, Lars Erik, et al.
Publicado: (2014)

Isolated limb perfusion for unresectable extremity cutaneous squamous cell carcinoma; an effective limb saving strategy
por: Huis in ’t Veld, Eva A., et al.
Publicado: (2018)

Isolated Limb Perfusion With Melphalan Triggers Immune Activation in Melanoma Patients
por: Johansson, Junko, et al.
Publicado: (2018)

Isolated limb infusion chemotherapy for melanoma: an overview of early experience at the Adelaide Melanoma Unit
por: Giles, Mitchell H, et al.
Publicado: (2013)

Leakage through the bone-marrow during isolated limb perfusion in the lower extremity
por: Katsarelias, Dimitrios, et al.
Publicado: (2019)

Molecular Aspects of the Isolated Limb Infusion Procedure
por: Teras, Jüri, et al.
Publicado: (2021)

Vascular Complications following Isolated Limb Perfusion for Local Recurrence of Extremity Melanoma: A Case Report and Literature Review
por: Trezzi, M., et al.
Publicado: (2011)

What Outcome Measures Are Reported in the Management of Acromioclavicular Joint Injuries?
por: Reintgen, Christian, et al.
Publicado: (2020)

Youth Baseball Caregiver Understanding of Safe Pitching Guidelines and Player Injury
por: Reintgen, Christian, et al.
Publicado: (2021)

Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb.
por: Klaase, J. M., et al.
Publicado: (1994)

Effects of the Introduction of Modern Immunotherapy on the Outcome of Isolated Limb Perfusion for Melanoma In-Transit Metastases
por: Holmberg, Carl-Jacob, et al.
Publicado: (2023)

Microdialysis and response during regional chemotherapy by isolated limb infusion of melphalan for limb malignancies
por: Thompson, J F, et al.
Publicado: (2001)

Indocyanine Green for Leakage Control in Isolated Limb Perfusion
por: Zucal, Isabel, et al.
Publicado: (2021)

The Effect of Temperature and Perfusion Time on Response, Toxicity, and Survival in Patients with In-transit Melanoma Metastases Treated with Isolated Limb Perfusion
por: Katsarelias, Dimitrios, et al.
Publicado: (2018)

Isolated Limb Perfusion on Nonmelanoma Skin Cancer for Limb Salvage: A Series of Four Cases
por: Jiménez Herevia, Aldo Edyair, et al.
Publicado: (2020)

Isolated Limb Infusion for Limb-Threatening, Unresectable Sarcoma: Past Progress, Current Applications, and Future Directions
por: DePalo, Danielle K., et al.
Publicado: (2023)

Response and Toxicity of Repeated Isolated Limb Perfusion (re-ILP) for Patients With In-Transit Metastases of Malignant Melanoma
por: Belgrano, Valerio, et al.
Publicado: (2019)

Role of Isolated Limb Perfusion in the Era of Targeted Therapies and Immunotherapy in Melanoma. A Systematic Review of The Literature
por: Sevilla-Ortega, Lourdes, et al.
Publicado: (2021)

The pathologic response of resected synovial sarcomas to hyperthermic isolated limb perfusion with melphalan and TNF-α: a comparison with the whole group of resected soft tissue sarcomas
por: Schwindenhammer, Benjamin, et al.
Publicado: (2013)

20 Years Experience of TNF-Based Isolated Limb Perfusion for In-Transit Melanoma Metastases: TNF Dose Matters
por: Deroose, Jan P., et al.
Publicado: (2011)

Isolated limb perfusion with hyperthermia and chemotherapy: predictive factors for regional toxicity
por: Neto, João Pedreira Duprat, et al.
Publicado: (2012)

Response to isolated limb perfusion and chemotherapy with epirubicin plus ifosfamide in a metastatic malignant ossifying fibromyxoid tumor
por: Provenzano, Salvatore, et al.
Publicado: (2017)

Treatment of in-transit Merkel cell carcinoma by isolated limb infusion with cytotoxic drugs
por: Hindmarch, Jake J, et al.
Publicado: (2022)

Isolated limb perfusion with melphalan activates interferon-stimulated genes to induce tumor regression in patients with melanoma in-transit metastasis
por: Johansson, Junko, et al.
Publicado: (2019)

Isolated lower extremity vasculitis leading to progressive critical limb ischemia
por: Parsa, Pouria, et al.
Publicado: (2017)

Long-Term Locoregional Vascular Morbidity After Isolated Limb Perfusion and External-Beam Radiotherapy for Soft Tissue Sarcoma of the Extremity
por: Hoven-Gondrie, Miriam L., et al.
Publicado: (2007)

Synovial distribution of “systemically” administered acetylsalicylic acid in the isolated perfused equine distal limb
por: Friebe, Maren, et al.
Publicado: (2013)

Clinical characteristics of critically ill cancer patients who are undergoing isolated limb perfusion
por: Ñamendys-Silva, Silvio A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_e8mu8sh511127l8peokjb058sj